BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 2, 2026
See today's BioWorld Asia
Home
» Other news to note for April 21, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for April 21, 2020
April 21, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 48Hour Discovery, 7 Hills, Afecta, AI Vivo, Aikido Pharma, Aligos, Anixa, Applied Biology, Applied Botanics, Applied DNA, Atomwise, Benitec, Biogen, Botanix, Cerespir, Chromadex, Clinigen, Cyclacel, Cynata, Dynavax, Eagle, Esperion, Fairjourney, Fujifilm, Fusion Antibodies, Generex, Ginkgo Bioworks, Halix, Hansoh, Iksuda, Immunitybio, Immutep, Inato, Inmune, Innocan, Inovio, Iontas, Khondrion, Kubota Vision, Legochem, Leo, Ligandal, Luxna, Moderna, Molecular Partners, Nantkwest, Nicox, Northern Data, Octapharma, Ontochem, Otsuka, Porton, Promis, Pulmatrix, Recce, Redhill, Retrotope, Roche, SAB, Samsung Bioepis, Sinovac, Soligenix, Som Biotech, Sosei, Starpharma, Takis Biotech, Transcelerate, Xenothera, Xylyx.
BioWorld Asia
Briefs
Other news to note